Patterns of seizure prophylaxis after oncologic neurosurgery
- PMID: 31834582
- DOI: 10.1007/s11060-019-03362-1
Patterns of seizure prophylaxis after oncologic neurosurgery
Abstract
Background: Evidence supporting routine postoperative antiepileptic drug (AED) prophylaxis following oncologic neurosurgery is limited, and actual practice patterns are largely unknown beyond survey data.
Objective: To describe patterns and predictors of postoperative AED prophylaxis following intracranial tumor surgery.
Methods: The MarketScan Database was used to analyze pharmacy claims data and clinical characteristics in a national sample over a 5-year period.
Results: Among 5895 patients in the cohort, levetiracetam was the most widely used AED for prophylaxis (78.5%) followed by phenytoin (20.5%). Prophylaxis was common but highly variable for patients who underwent open resection of supratentorial intraparenchymal tumors (62.5%, reference) or meningiomas (61.9%). In multivariate analysis, biopsies were less likely to receive prophylaxis (44.8%, OR 0.47, 95% CI 0.33-0.67), and there was near consensus against prophylaxis for infratentorial (9.7%, OR 0.07, CI 0.05-0.09) and transsphenoidal procedures (0.4%, OR 0.003, CI 0.001-0.010). Primary malignancies (52.1%, reference) and secondary metastases (42.2%) were more likely to receive prophylaxis than benign tumors (23.0%, OR 0.63, CI 0.48-0.83), as were patients discharged with home services and patients in the Northeast. There was a large spike in duration of AED use at approximately 30 days.
Conclusions: Use of seizure prophylaxis following intracranial biopsies and supratentorial resections is highly variable, consistent with a lack of guidelines or consensus. Current practice patterns do not support a clear standard of care and may be driven in part by geographic variation, availability of post-discharge services, and electronic prescribing defaults rather than evidence. Given uncertainty regarding effectiveness, indications, and appropriate duration of AED prophylaxis, well-powered trials are needed.
Keywords: Antiepileptic drugs; Brain tumor; Glioma; Meningioma; Oncologic neurosurgery; Postoperative seizures; Seizure prophylaxis.
Similar articles
-
Prophylactic antiepileptic drug administration following brain tumor resection: results of a recent AANS/CNS Section on Tumors survey.J Neurosurg. 2017 Jun;126(6):1772-1778. doi: 10.3171/2016.4.JNS16245. Epub 2016 Jun 24. J Neurosurg. 2017. PMID: 27341048
-
A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors.J Neurosurg. 2013 Apr;118(4):873-883. doi: 10.3171/2012.12.JNS111970. Epub 2013 Feb 8. J Neurosurg. 2013. PMID: 23394340 Free PMC article. Clinical Trial.
-
Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours: a phase II prospective, randomised study.J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1158-62. doi: 10.1136/jnnp-2014-308584. Epub 2014 Dec 15. J Neurol Neurosurg Psychiatry. 2015. PMID: 25511789 Clinical Trial.
-
Phenytoin versus levetiracetam as prophylaxis for postcraniotomy seizure in patients with no history of seizures: systematic review and meta-analysis.J Neurosurg. 2019 Jun 1;130(6):2063-2070. doi: 10.3171/2018.4.JNS1891. Epub 2018 Jul 1. J Neurosurg. 2019. PMID: 30004278
-
Intracranial meningiomas and seizures: a review of the literature.Acta Neurochir (Wien). 2015 Sep;157(9):1541-8. doi: 10.1007/s00701-015-2495-4. Epub 2015 Jul 11. Acta Neurochir (Wien). 2015. PMID: 26163256 Review.
Cited by
-
Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management.Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i58-i66. doi: 10.1093/noajnl/vdac136. eCollection 2023 May. Neurooncol Adv. 2023. PMID: 37287578 Free PMC article.
-
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.Neuro Oncol. 2023 Jul 6;25(7):1200-1224. doi: 10.1093/neuonc/noad038. Neuro Oncol. 2023. PMID: 36843451 Free PMC article.
-
Predictors for the Occurrence of Seizures in Meningioma.Cancers (Basel). 2024 Aug 31;16(17):3046. doi: 10.3390/cancers16173046. Cancers (Basel). 2024. PMID: 39272904 Free PMC article.
-
Seizures, Edema, Thrombosis, and Hemorrhages: An Update Review on the Medical Management of Gliomas.Front Oncol. 2021 Mar 22;11:617966. doi: 10.3389/fonc.2021.617966. eCollection 2021. Front Oncol. 2021. PMID: 33828976 Free PMC article. Review.
-
Risk factors for thrombocytopenia associated with intravenous valproic acid therapy in pediatric patients undergoing neurosurgical operations.Sci Rep. 2025 Apr 21;15(1):13675. doi: 10.1038/s41598-025-98870-8. Sci Rep. 2025. PMID: 40258981 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical